Articles liés à Formulation and Evaluation of Glipizide Solid Dispersion

Formulation and Evaluation of Glipizide Solid Dispersion - Couverture souple

Shivalingam, M.R.; Durgabhavani, G.; Arulkumaran, K.S.G.

 
9783659354366: Formulation and Evaluation of Glipizide Solid Dispersion

Synopsis

More than 90% of the drugs arrowed since 1995 have poor solubility, poor permeability and more than 40% of new chemical entities have little or no water solubility. Glipizide is a class-II drug which is poorly soluble. So the solubility of the drug is enhanced by solid dispersion using solvent evaporation method. Drug and carrier in different ratios like 1: 1, 1: 2, 1: 3 by keeping drug weight constant. The prepared solid dispersions were evaluated for their routine tests like Phase solubility, Invitro dissolutoion study and the results were observed and tabulated. FT-IR study was also done for drug, polymers and 1: 3 ratios of drug: carrier by KBr pelleting method. From the study it was confirmed that no physical interactions were found. Also from the study it was concluded that 1: 3 ratio of drug:carrier shows better phase solubility and invitro dissolution rate.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

More than 90% of the drugs arrowed since 1995 have poor solubility, poor permeability and more than 40% of new chemical entities have little or no water solubility. Glipizide is a class-II drug which is poorly soluble. So the solubility of the drug is enhanced by solid dispersion using solvent evaporation method. Drug and carrier in different ratios like 1: 1, 1: 2, 1: 3 by keeping drug weight constant. The prepared solid dispersions were evaluated for their routine tests like Phase solubility, Invitro dissolutoion study and the results were observed and tabulated. FT-IR study was also done for drug, polymers and 1: 3 ratios of drug: carrier by KBr pelleting method. From the study it was confirmed that no physical interactions were found. Also from the study it was concluded that 1: 3 ratio of drug:carrier shows better phase solubility and invitro dissolution rate.

Biographie de l'auteur

M.R.Shivalingam M.Pharm.,(Ph.D),specialised in Pharmaceutics Working as Assistant Professor in Victoria College of Pharmacy,Guntur,Andhra Pradesh,India.Interested in Transdermal Drug Delivery development and serving as Reviewer and Editorial Board member in Various International Pharmacy Journals.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.